Results 271 to 280 of about 493,161 (298)
Some of the next articles are maybe not open access.

Circulating Tumor Cells

2010
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F, Hayes, Jeffrey B, Smerage
openaire   +2 more sources

Circulating Tumor Cells

Pathology Case Reviews, 2014
Circulating tumor cells (CTCs) are tumor cells that shed from primary tumor and circulate in peripheral blood, and can be a useful clinical marker in early diagnosis and monitoring therapeutic effects for patients with malignant tumors. Detection of rare CTCs contaminated among a large number of hematologic cells presents a technical challenge, but ...
Jeanny B. Aragon-Ching   +2 more
openaire   +2 more sources

Circulating Tumor Cell Enrichment Technologies

2019
Circulating tumor cells (CTCs) are responsible for the metastatic spread of cancer and therefore are extremely valuable not only for basic research on cancer metastasis but also as potential biomarkers in diagnosing and managing cancer in the clinic. While relatively non-invasive access to the blood tissue presents an opportunity, CTCs are mixed with ...
Mert, Boya   +4 more
openaire   +2 more sources

Digital Circulating Tumor Cells Quantification

Analytical Chemistry
Circulating tumor cells (CTCs) are an emerging but vital biomarker for cancer management. An efficient methodology for accurately quantifying CTCs remains challenging due to their rareness. Here, we develop a digital CTC detection strategy using partitioning instead of enrichment to quantify CTCs.
Jidong Wang   +3 more
openaire   +2 more sources

Circulating Tumor Cells

Surgical Pathology Clinics, 2018
Konstantinos L. Georgiadis   +6 more
openaire   +2 more sources

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Michael L Cheng   +2 more
exaly  

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Carl M Gay   +2 more
exaly  

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov   +2 more
exaly  

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Kimberly D Miller   +2 more
exaly  

Home - About - Disclaimer - Privacy